speb/financial-data huggingface dataset:
BIOS.BR cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 587000.00
BIOS.BR income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -2716000.00
BIOS.BR cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -1000.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Net PPE: 697000.00
BIOS.BR cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: 6000.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -25901000.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Non Current Deferred Revenue: 0.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 80000.00
BIOS.BR income_statement (annual, 2023-12-31) — Normalized EBITDA: -7992000.00
BIOS.BR income_statement (annual, 2023-12-31) — Normalized Income: -9508647.86
BIOS.BR cash_flow (annual, 2023-12-31) — Operating Cash Flow: -3470000.00
BIOS.BR income_statement (annual, 2023-12-31) — Operating Income: -7040000.00
BIOS.BR income_statement (annual, 2023-12-31) — Operating Revenue: 0.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 163181474.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Other Current Assets: 273000.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 330000.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 2989000.00
BIOS.BR cash_flow (annual, 2023-12-31) — Other Non Cash Items: -28000.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 137000.00
BIOS.BR income_statement (annual, 2023-12-31) — Other Operating Expenses: 875000.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Other Payable: 277000.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Other Properties: 56000.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Other Receivables: 181000.00
BIOS.BR income_statement (annual, 2023-12-31) — Other Special Charges: 182000.00
BIOS.BR income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 0.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Payables: 3599000.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 49000.00
BIOS.BR income_statement (annual, 2023-12-31) — Pretax Income: -29028000.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Properties: 0.00
BIOS.BR income_statement (annual, 2023-12-31) — Reconciled Depreciation: 243000.00
BIOS.BR income_statement (annual, 2023-12-31) — Rent And Landing Fees: 259000.00
BIOS.BR income_statement (annual, 2023-12-31) — Rent Expense Supplemental: 259000.00
BIOS.BR cash_flow (annual, 2023-12-31) — Repayment Of Debt: -413000.00
BIOS.BR income_statement (annual, 2023-12-31) — Research And Development: 3931000.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Retained Earnings: -34887000.00
BIOS.BR cash_flow (annual, 2023-12-31) — Sale Of Business: 0.00
BIOS.BR cash_flow (annual, 2023-12-31) — Sale Of PPE: 6000.00
BIOS.BR income_statement (annual, 2023-12-31) — Selling General And Administration: 1408000.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Share Issued: 163181474.00
BIOS.BR income_statement (annual, 2023-12-31) — Special Income Charges: -16276000.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Stockholders Equity: -22912000.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Tangible Book Value: -25901000.00
BIOS.BR income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -4647.86
BIOS.BR income_statement (annual, 2023-12-31) — Tax Provision: -7000.00
BIOS.BR income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Taxes Receivable: 981000.00
BIOS.BR cash_flow (annual, 2023-12-31) — Taxes Refund Paid: 0.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Total Assets: 9559000.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Total Capitalization: -7339000.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Total Debt: 28161000.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: -22705000.00
BIOS.BR income_statement (annual, 2023-12-31) — Total Expenses: 7040000.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 32264000.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 7713000.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 16420000.00
BIOS.BR income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -7040000.00
BIOS.BR income_statement (annual, 2023-12-31) — Total Other Finance Cost: 1254000.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Total Tax Payable: 5000.00
BIOS.BR income_statement (annual, 2023-12-31) — Total Unusual Items: -19274000.00
BIOS.BR income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -19274000.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
BIOS.BR balance_sheet (annual, 2023-12-31) — Working Capital: -13998000.00
BIOS.BR income_statement (annual, 2023-12-31) — Write Off: 16094000.00
BIOV.SW income_statement (annual, 2024-12-31) — +Operating Expense: 14773000.00
BIOV.SW income_statement (annual, 2024-12-31) — +Total Revenue: 0.00
BIOV.SW balance_sheet (annual, 2024-12-31) — Accounts Payable: 706000.00
BIOV.SW balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 706000.00
BIOV.SW balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -368000.00
BIOV.SW balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -368000.00
BIOV.SW balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 87398000.00
BIOV.SW balance_sheet (quarterly, 2024-12-31) — Additional Paid In Capital: 87398000.00
BIOV.SW income_statement (annual, 2024-12-31) — Basic Average Shares: 5914506.00
BIOV.SW income_statement (annual, 2024-12-31) — Basic EPS: -3.16
BIOV.SW cash_flow (annual, 2024-12-31) — Beginning Cash Position: 24376000.00
BIOV.SW cash_flow (annual, 2024-12-31) — Capital Expenditure: -38000.00
BIOV.SW balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 353000.00
BIOV.SW balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 353000.00
BIOV.SW balance_sheet (annual, 2024-12-31) — Capital Stock: 3692000.00
BIOV.SW balance_sheet (quarterly, 2024-12-31) — Capital Stock: 3692000.00
BIOV.SW balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 26619000.00
BIOV.SW balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 26619000.00
BIOV.SW balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 32619000.00
BIOV.SW balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 32619000.00
BIOV.SW balance_sheet (annual, 2024-12-31) — Cash Equivalents: 16654000.00
BIOV.SW balance_sheet (quarterly, 2024-12-31) — Cash Equivalents: 16654000.00
BIOV.SW balance_sheet (annual, 2024-12-31) — Cash Financial: 9965000.00
BIOV.SW balance_sheet (quarterly, 2024-12-31) — Cash Financial: 9965000.00
BIOV.SW cash_flow (annual, 2024-12-31) — Change In Payable: -2801000.00
BIOV.SW cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 3359000.00
BIOV.SW cash_flow (annual, 2024-12-31) — Change In Working Capital: 558000.00
BIOV.SW cash_flow (annual, 2024-12-31) — Changes In Cash: 1581000.00
BIOV.SW balance_sheet (annual, 2024-12-31) — Common Stock: 3692000.00
BIOV.SW balance_sheet (quarterly, 2024-12-31) — Common Stock: 3692000.00
BIOV.SW balance_sheet (annual, 2024-12-31) — Common Stock Equity: 10682000.00
BIOV.SW balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: 10682000.00
BIOV.SW cash_flow (annual, 2024-12-31) — Common Stock Issuance: 19827000.00
BIOV.SW income_statement (annual, 2024-12-31) — Cost Of Revenue: 3949000.00
BIOV.SW balance_sheet (annual, 2024-12-31) — Current Assets: 34398000.00
BIOV.SW balance_sheet (quarterly, 2024-12-31) — Current Assets: 34398000.00
BIOV.SW balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 221000.00
BIOV.SW balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 221000.00
BIOV.SW balance_sheet (annual, 2024-12-31) — Current Debt: 2983000.00
BIOV.SW balance_sheet (quarterly, 2024-12-31) — Current Debt: 2983000.00
BIOV.SW balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 3204000.00
BIOV.SW balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 3204000.00
BIOV.SW balance_sheet (annual, 2024-12-31) — Current Liabilities: 9673000.00
BIOV.SW balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 9673000.00
BIOV.SW cash_flow (annual, 2024-12-31) — Depreciation: 282000.00
BIOV.SW cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 282000.00
BIOV.SW income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 170000.00
BIOV.SW income_statement (annual, 2024-12-31) — Depreciation Income Statement: 170000.00
BIOV.SW balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 0.00
BIOV.SW balance_sheet (quarterly, 2024-12-31) — Derivative Product Liabilities: 0.00
BIOV.SW income_statement (annual, 2024-12-31) — Diluted Average Shares: 5914506.00
BIOV.SW income_statement (annual, 2024-12-31) — Diluted EPS: -3.16
BIOV.SW income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -18719000.00
BIOV.SW income_statement (annual, 2024-12-31) — EBIT: -17682000.00
BIOV.SW income_statement (annual, 2024-12-31) — EBITDA: -17400000.00
BIOV.SW cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 662000.00
BIOV.SW cash_flow (annual, 2024-12-31) — End Cash Position: 26619000.00
BIOV.SW cash_flow (annual, 2024-12-31) — Financing Cash Flow: 19193000.00
BIOV.SW cash_flow (annual, 2024-12-31) — Free Cash Flow: -15612000.00
BIOV.SW cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: -431000.00
BIOV.SW balance_sheet (annual, 2024-12-31) — Gross PPE: 926000.00
BIOV.SW balance_sheet (quarterly, 2024-12-31) — Gross PPE: 926000.00
BIOV.SW income_statement (annual, 2024-12-31) — Gross Profit: -3949000.00
BIOV.SW income_statement (annual, 2024-12-31) — Interest Expense: 1037000.00
BIOV.SW income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 1037000.00
BIOV.SW income_statement (annual, 2024-12-31) — Interest Income: 497000.00
BIOV.SW income_statement (annual, 2024-12-31) — Interest Income Non Operating: 497000.00
BIOV.SW cash_flow (annual, 2024-12-31) — Interest Paid Cfo: -78000.00
BIOV.SW cash_flow (annual, 2024-12-31) — Interest Received Cfo: 575000.00
BIOV.SW balance_sheet (annual, 2024-12-31) — Invested Capital: 27294000.00
BIOV.SW balance_sheet (quarterly, 2024-12-31) — Invested Capital: 27294000.00
BIOV.SW cash_flow (annual, 2024-12-31) — Investing Cash Flow: -2038000.00
BIOV.SW cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 19827000.00
BIOV.SW cash_flow (annual, 2024-12-31) — Issuance Of Debt: 0.00
BIOV.SW balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 132000.00
BIOV.SW balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 132000.00
BIOV.SW balance_sheet (annual, 2024-12-31) — Long Term Debt: 13629000.00
BIOV.SW balance_sheet (quarterly, 2024-12-31) — Long Term Debt: 13629000.00
BIOV.SW balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 13761000.00
BIOV.SW balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 13761000.00
BIOV.SW cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 0.00
BIOV.SW cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -30000.00
BIOV.SW balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 140000.00
BIOV.SW balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 140000.00
BIOV.SW balance_sheet (annual, 2024-12-31) — Minority Interest: 0.00
BIOV.SW balance_sheet (quarterly, 2024-12-31) — Minority Interest: 0.00
BIOV.SW cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 19827000.00
BIOV.SW cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: -128000.00
BIOV.SW income_statement (annual, 2024-12-31) — Net Income: -18719000.00
BIOV.SW income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -18719000.00
BIOV.SW income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -18719000.00
BIOV.SW income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -18719000.00
BIOV.SW income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -18719000.00
BIOV.SW cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -18719000.00
BIOV.SW income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -18719000.00
BIOV.SW income_statement (annual, 2024-12-31) — Net Interest Income: -556000.00
BIOV.SW cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -2000000.00
BIOV.SW cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -30000.00
BIOV.SW cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -30000.00
BIOV.SW income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -556000.00
BIOV.SW balance_sheet (annual, 2024-12-31) — Net PPE: 558000.00
BIOV.SW balance_sheet (quarterly, 2024-12-31) — Net PPE: 558000.00
BIOV.SW cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -38000.00
BIOV.SW balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 10682000.00
BIOV.SW balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: 10682000.00
BIOV.SW balance_sheet (annual, 2024-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 840000.00
BIOV.SW balance_sheet (quarterly, 2024-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 840000.00
BIOV.SW income_statement (annual, 2024-12-31) — Normalized EBITDA: -17831000.00
BIOV.SW income_statement (annual, 2024-12-31) — Normalized Income: -19150000.00
BIOV.SW cash_flow (annual, 2024-12-31) — Operating Cash Flow: -15574000.00
BIOV.SW income_statement (annual, 2024-12-31) — Operating Income: -18722000.00
BIOV.SW income_statement (annual, 2024-12-31) — Operating Revenue: 0.00
BIOV.SW balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 5914506.00
BIOV.SW balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 5914506.00
BIOV.SW cash_flow (annual, 2024-12-31) — Other Non Cash Items: 564000.00
BIOV.SW balance_sheet (annual, 2024-12-31) — Other Payable: 67000.00
BIOV.SW balance_sheet (quarterly, 2024-12-31) — Other Payable: 67000.00
BIOV.SW balance_sheet (annual, 2024-12-31) — Other Properties: 786000.00
BIOV.SW balance_sheet (quarterly, 2024-12-31) — Other Properties: 786000.00
BIOV.SW balance_sheet (annual, 2024-12-31) — Other Receivables: 28000.00
BIOV.SW balance_sheet (quarterly, 2024-12-31) — Other Receivables: 28000.00
BIOV.SW balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 6000000.00
BIOV.SW balance_sheet (quarterly, 2024-12-31) — Other Short Term Investments: 6000000.00
BIOV.SW income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
BIOV.SW balance_sheet (annual, 2024-12-31) — Payables: 773000.00
BIOV.SW balance_sheet (quarterly, 2024-12-31) — Payables: 773000.00
BIOV.SW cash_flow (annual, 2024-12-31) — Pension And Employee Benefit Expense: -53000.00
BIOV.SW balance_sheet (annual, 2024-12-31) — Prepaid Assets: 491000.00
BIOV.SW balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 491000.00
BIOV.SW income_statement (annual, 2024-12-31) — Pretax Income: -18719000.00
BIOV.SW cash_flow (annual, 2024-12-31) — Purchase Of Investment: -17000000.00
BIOV.SW cash_flow (annual, 2024-12-31) — Purchase Of PPE: -38000.00
BIOV.SW income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 3949000.00
BIOV.SW income_statement (annual, 2024-12-31) — Reconciled Depreciation: 282000.00
BIOV.SW cash_flow (annual, 2024-12-31) — Repayment Of Debt: -30000.00
BIOV.SW income_statement (annual, 2024-12-31) — Research And Development: 12947000.00
BIOV.SW balance_sheet (annual, 2024-12-31) — Retained Earnings: -80341000.00
BIOV.SW balance_sheet (quarterly, 2024-12-31) — Retained Earnings: -80341000.00
BIOV.SW cash_flow (annual, 2024-12-31) — Sale Of Investment: 15000000.00
BIOV.SW balance_sheet (annual, 2024-12-31) — Share Issued: 5914506.00
BIOV.SW balance_sheet (quarterly, 2024-12-31) — Share Issued: 5914506.00
BIOV.SW cash_flow (annual, 2024-12-31) — Stock Based Compensation: 1856000.00
BIOV.SW balance_sheet (annual, 2024-12-31) — Stockholders Equity: 10682000.00
BIOV.SW balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 10682000.00
BIOV.SW balance_sheet (annual, 2024-12-31) — Tangible Book Value: 10682000.00
BIOV.SW balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: 10682000.00
BIOV.SW income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
BIOV.SW income_statement (annual, 2024-12-31) — Tax Provision: 0.00
BIOV.SW income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
BIOV.SW balance_sheet (annual, 2024-12-31) — Taxes Receivable: 1260000.00
BIOV.SW balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 1260000.00
BIOV.SW balance_sheet (annual, 2024-12-31) — Total Assets: 34956000.00
BIOV.SW balance_sheet (quarterly, 2024-12-31) — Total Assets: 34956000.00
BIOV.SW balance_sheet (annual, 2024-12-31) — Total Capitalization: 24311000.00
BIOV.SW balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 24311000.00
BIOV.SW balance_sheet (annual, 2024-12-31) — Total Debt: 16965000.00
BIOV.SW balance_sheet (quarterly, 2024-12-31) — Total Debt: 16965000.00
BIOV.SW balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 10682000.00
BIOV.SW balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 10682000.00
BIOV.SW income_statement (annual, 2024-12-31) — Total Expenses: 18722000.00
BIOV.SW balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 24274000.00
BIOV.SW balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 24274000.00
BIOV.SW balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 558000.00
BIOV.SW balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 558000.00
BIOV.SW balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 14601000.00
BIOV.SW balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 14601000.00
BIOV.SW income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -18722000.00
BIOV.SW income_statement (annual, 2024-12-31) — Total Other Finance Cost: 16000.00
BIOV.SW income_statement (annual, 2024-12-31) — Total Unusual Items: 431000.00
BIOV.SW income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 431000.00
BIOV.SW balance_sheet (annual, 2024-12-31) — Working Capital: 24725000.00
BIOV.SW balance_sheet (quarterly, 2024-12-31) — Working Capital: 24725000.00
BIOV.SW balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 776000.00
BIOV.SW balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 155600000.00
BIOV.SW balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 247000.00
BIOV.SW balance_sheet (quarterly, 2025-06-30) — Capital Stock: 5838000.00
BIOV.SW balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 92071000.00
BIOV.SW balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 92071000.00
BIOV.SW balance_sheet (quarterly, 2025-06-30) — Cash Equivalents: 0.00
BIOV.SW balance_sheet (quarterly, 2025-06-30) — Cash Financial: 92071000.00
BIOV.SW balance_sheet (quarterly, 2025-06-30) — Common Stock: 5838000.00
BIOV.SW balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 69875000.00
BIOV.SW balance_sheet (quarterly, 2025-06-30) — Current Assets: 94281000.00
BIOV.SW balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 228000.00
BIOV.SW balance_sheet (quarterly, 2025-06-30) — Current Debt: 4011000.00
BIOV.SW balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 4239000.00
BIOV.SW balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 10206000.00
BIOV.SW balance_sheet (quarterly, 2025-06-30) — Derivative Product Liabilities: 0.00
BIOV.SW balance_sheet (quarterly, 2025-06-30) — Gross PPE: 441000.00
BIOV.SW balance_sheet (quarterly, 2025-06-30) — Invested Capital: 87875000.00
BIOV.SW balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 19000.00
BIOV.SW balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 13989000.00
BIOV.SW balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 14008000.00
BIOV.SW balance_sheet (quarterly, 2025-06-30) — Net PPE: 441000.00
BIOV.SW balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 69875000.00
BIOV.SW balance_sheet (quarterly, 2025-06-30) — Non Current Pension And Other Postretirement Benefit Plans: 633000.00
BIOV.SW balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 5837986.00
BIOV.SW balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 1135000.00
BIOV.SW balance_sheet (quarterly, 2025-06-30) — Other Properties: 441000.00
BIOV.SW balance_sheet (quarterly, 2025-06-30) — Other Receivables: 2210000.00
BIOV.SW balance_sheet (quarterly, 2025-06-30) — Payables: 776000.00
BIOV.SW balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -90945000.00
BIOV.SW balance_sheet (quarterly, 2025-06-30) — Share Issued: 5837986.00
BIOV.SW balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 69875000.00
BIOV.SW balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 69875000.00
BIOV.SW balance_sheet (quarterly, 2025-06-30) — Total Assets: 94722000.00
BIOV.SW balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 83864000.00
BIOV.SW balance_sheet (quarterly, 2025-06-30) — Total Debt: 18247000.00
BIOV.SW balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 69875000.00
BIOV.SW balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 24847000.00
BIOV.SW balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 441000.00
BIOV.SW balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 14641000.00
BIOV.SW balance_sheet (quarterly, 2025-06-30) — Working Capital: 84075000.00
BIOV.SW income_statement (annual, 2025-12-31) — +Operating Expense: 16870000.00
BIOV.SW income_statement (annual, 2025-12-31) — +Total Revenue: 800000.00
BIOV.SW balance_sheet (annual, 2025-12-31) — Accounts Payable: 2470000.00
BIOV.SW balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 2470000.00
BIOV.SW balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -377000.00
BIOV.SW balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -377000.00
BIOV.SW balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 155600000.00
BIOV.SW balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 155600000.00
BIOV.SW income_statement (annual, 2025-12-31) — Basic Average Shares: 5614793.00
BIOV.SW income_statement (annual, 2025-12-31) — Basic EPS: -3.89
BIOV.SW cash_flow (annual, 2025-12-31) — Beginning Cash Position: 26619000.00
BIOV.SW cash_flow (annual, 2025-12-31) — Capital Expenditure: -216000.00
BIOV.SW balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 416000.00
BIOV.SW balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 416000.00
BIOV.SW balance_sheet (annual, 2025-12-31) — Capital Stock: 5848000.00
BIOV.SW balance_sheet (quarterly, 2025-12-31) — Capital Stock: 5848000.00
BIOV.SW balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 82505000.00
BIOV.SW balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 82505000.00
BIOV.SW balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 82505000.00
BIOV.SW balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 82505000.00
BIOV.SW balance_sheet (annual, 2025-12-31) — Cash Equivalents: 5583000.00
BIOV.SW balance_sheet (quarterly, 2025-12-31) — Cash Equivalents: 5583000.00
BIOV.SW balance_sheet (annual, 2025-12-31) — Cash Financial: 76922000.00
BIOV.SW balance_sheet (quarterly, 2025-12-31) — Cash Financial: 76922000.00
BIOV.SW cash_flow (annual, 2025-12-31) — Change In Payable: 2687000.00
BIOV.SW cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -5632000.00
BIOV.SW cash_flow (annual, 2025-12-31) — Change In Working Capital: -2945000.00
BIOV.SW cash_flow (annual, 2025-12-31) — Changes In Cash: 56413000.00
BIOV.SW balance_sheet (annual, 2025-12-31) — Common Stock: 5848000.00
BIOV.SW balance_sheet (quarterly, 2025-12-31) — Common Stock: 5848000.00
BIOV.SW balance_sheet (annual, 2025-12-31) — Common Stock Equity: 59811000.00
BIOV.SW balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 59811000.00
BIOV.SW cash_flow (annual, 2025-12-31) — Common Stock Issuance: 76843000.00
BIOV.SW income_statement (annual, 2025-12-31) — Cost Of Revenue: 3893000.00
BIOV.SW balance_sheet (annual, 2025-12-31) — Current Assets: 89871000.00
BIOV.SW balance_sheet (quarterly, 2025-12-31) — Current Assets: 89871000.00
BIOV.SW balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 259000.00
BIOV.SW balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 259000.00
BIOV.SW balance_sheet (annual, 2025-12-31) — Current Debt: 30000.00
BIOV.SW balance_sheet (quarterly, 2025-12-31) — Current Debt: 30000.00
BIOV.SW balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 289000.00
BIOV.SW balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 289000.00
BIOV.SW balance_sheet (annual, 2025-12-31) — Current Liabilities: 8896000.00
BIOV.SW balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 8896000.00
BIOV.SW cash_flow (annual, 2025-12-31) — Depreciation: 297000.00
BIOV.SW cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 297000.00
BIOV.SW income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 159000.00
BIOV.SW income_statement (annual, 2025-12-31) — Depreciation Income Statement: 159000.00
BIOV.SW balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 0.00
BIOV.SW balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 0.00
BIOV.SW income_statement (annual, 2025-12-31) — Diluted Average Shares: 5614793.00
BIOV.SW income_statement (annual, 2025-12-31) — Diluted EPS: -3.89
BIOV.SW income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -21830000.00
BIOV.SW income_statement (annual, 2025-12-31) — EBIT: -20737000.00
BIOV.SW income_statement (annual, 2025-12-31) — EBITDA: -20440000.00
BIOV.SW cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -527000.00
BIOV.SW cash_flow (annual, 2025-12-31) — End Cash Position: 82505000.00
BIOV.SW cash_flow (annual, 2025-12-31) — Financing Cash Flow: 72575000.00
BIOV.SW cash_flow (annual, 2025-12-31) — Free Cash Flow: -22162000.00
BIOV.SW cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -182000.00
BIOV.SW balance_sheet (annual, 2025-12-31) — Gross PPE: 1142000.00
BIOV.SW balance_sheet (quarterly, 2025-12-31) — Gross PPE: 1142000.00
BIOV.SW income_statement (annual, 2025-12-31) — Gross Profit: -3093000.00
BIOV.SW income_statement (annual, 2025-12-31) — Interest Expense: 1077000.00
BIOV.SW income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 1077000.00
BIOV.SW income_statement (annual, 2025-12-31) — Interest Income: 45000.00
BIOV.SW income_statement (annual, 2025-12-31) — Interest Income Non Operating: 45000.00
BIOV.SW cash_flow (annual, 2025-12-31) — Interest Paid Cfo: -35000.00
BIOV.SW cash_flow (annual, 2025-12-31) — Interest Received Cfo: 51000.00
BIOV.SW balance_sheet (annual, 2025-12-31) — Invested Capital: 81124000.00
BIOV.SW balance_sheet (quarterly, 2025-12-31) — Invested Capital: 81124000.00
BIOV.SW cash_flow (annual, 2025-12-31) — Investing Cash Flow: 5784000.00
BIOV.SW cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 76843000.00
BIOV.SW cash_flow (annual, 2025-12-31) — Issuance Of Debt: 6926000.00
BIOV.SW balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 157000.00
BIOV.SW balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 157000.00
BIOV.SW balance_sheet (annual, 2025-12-31) — Long Term Debt: 21283000.00
BIOV.SW balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 21283000.00
BIOV.SW balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 21440000.00
BIOV.SW balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 21440000.00
BIOV.SW cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 6926000.00
BIOV.SW cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -4030000.00
BIOV.SW balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 138000.00
BIOV.SW balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 138000.00
BIOV.SW balance_sheet (annual, 2025-12-31) — Minority Interest: 0.00
BIOV.SW balance_sheet (quarterly, 2025-12-31) — Minority Interest: 0.00
BIOV.SW cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 76843000.00
BIOV.SW cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 10000.00
BIOV.SW income_statement (annual, 2025-12-31) — Net Income: -21830000.00
BIOV.SW income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -21830000.00
BIOV.SW income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -21830000.00
BIOV.SW income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -21830000.00
BIOV.SW income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -21830000.00
BIOV.SW cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -21814000.00
BIOV.SW income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -21830000.00
BIOV.SW income_statement (annual, 2025-12-31) — Net Interest Income: -2023000.00
BIOV.SW cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 6000000.00
BIOV.SW cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 2896000.00
BIOV.SW cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 2896000.00
BIOV.SW income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -2023000.00
BIOV.SW balance_sheet (annual, 2025-12-31) — Net PPE: 765000.00
BIOV.SW balance_sheet (quarterly, 2025-12-31) — Net PPE: 765000.00
BIOV.SW cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -216000.00
BIOV.SW balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 59811000.00
BIOV.SW balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 59811000.00
BIOV.SW balance_sheet (annual, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 489000.00
BIOV.SW balance_sheet (quarterly, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 489000.00
BIOV.SW income_statement (annual, 2025-12-31) — Normalized EBITDA: -20622000.00
BIOV.SW income_statement (annual, 2025-12-31) — Normalized Income: -21996530.00
BIOV.SW cash_flow (annual, 2025-12-31) — Operating Cash Flow: -21946000.00
BIOV.SW income_statement (annual, 2025-12-31) — Operating Income: -19963000.00
BIOV.SW income_statement (annual, 2025-12-31) — Operating Revenue: 800000.00
BIOV.SW cash_flow (annual, 2025-12-31) — Other Non Cash Items: 1987000.00
BIOV.SW balance_sheet (annual, 2025-12-31) — Other Payable: 161000.00
BIOV.SW balance_sheet (quarterly, 2025-12-31) — Other Payable: 161000.00
BIOV.SW balance_sheet (annual, 2025-12-31) — Other Properties: 1004000.00
BIOV.SW balance_sheet (quarterly, 2025-12-31) — Other Properties: 1004000.00
BIOV.SW balance_sheet (annual, 2025-12-31) — Other Receivables: 904000.00
BIOV.SW balance_sheet (quarterly, 2025-12-31) — Other Receivables: 904000.00
BIOV.SW income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
BIOV.SW balance_sheet (annual, 2025-12-31) — Payables: 2631000.00
BIOV.SW balance_sheet (quarterly, 2025-12-31) — Payables: 2631000.00
BIOV.SW cash_flow (annual, 2025-12-31) — Pension And Employee Benefit Expense: 22000.00
BIOV.SW balance_sheet (annual, 2025-12-31) — Prepaid Assets: 4931000.00
BIOV.SW balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 4931000.00
BIOV.SW income_statement (annual, 2025-12-31) — Pretax Income: -21814000.00
BIOV.SW cash_flow (annual, 2025-12-31) — Purchase Of Investment: 0.00
BIOV.SW cash_flow (annual, 2025-12-31) — Purchase Of PPE: -216000.00
BIOV.SW income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 3893000.00
BIOV.SW income_statement (annual, 2025-12-31) — Reconciled Depreciation: 297000.00
BIOV.SW cash_flow (annual, 2025-12-31) — Repayment Of Debt: -4030000.00
BIOV.SW income_statement (annual, 2025-12-31) — Research And Development: 16502000.00
BIOV.SW balance_sheet (annual, 2025-12-31) — Retained Earnings: -101126000.00
BIOV.SW balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -101126000.00
BIOV.SW cash_flow (annual, 2025-12-31) — Sale Of Investment: 6000000.00
BIOV.SW cash_flow (annual, 2025-12-31) — Stock Based Compensation: 663000.00
BIOV.SW balance_sheet (annual, 2025-12-31) — Stockholders Equity: 59811000.00
BIOV.SW balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 59811000.00
BIOV.SW balance_sheet (annual, 2025-12-31) — Tangible Book Value: 59811000.00
BIOV.SW balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 59811000.00
BIOV.SW income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 15470.00
BIOV.SW income_statement (annual, 2025-12-31) — Tax Provision: 16000.00
BIOV.SW income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.09
BIOV.SW balance_sheet (annual, 2025-12-31) — Taxes Receivable: 1531000.00
BIOV.SW balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 1531000.00
BIOV.SW balance_sheet (annual, 2025-12-31) — Total Assets: 90636000.00
BIOV.SW balance_sheet (quarterly, 2025-12-31) — Total Assets: 90636000.00
BIOV.SW balance_sheet (annual, 2025-12-31) — Total Capitalization: 81094000.00
BIOV.SW balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 81094000.00
BIOV.SW balance_sheet (annual, 2025-12-31) — Total Debt: 21729000.00
BIOV.SW balance_sheet (quarterly, 2025-12-31) — Total Debt: 21729000.00
BIOV.SW balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 59811000.00
BIOV.SW balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 59811000.00
BIOV.SW income_statement (annual, 2025-12-31) — Total Expenses: 20763000.00
BIOV.SW balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 30825000.00
BIOV.SW balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 30825000.00
BIOV.SW balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 765000.00
BIOV.SW balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 765000.00
BIOV.SW balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 21929000.00
BIOV.SW balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 21929000.00
BIOV.SW income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -19963000.00
BIOV.SW income_statement (annual, 2025-12-31) — Total Other Finance Cost: 991000.00
BIOV.SW income_statement (annual, 2025-12-31) — Total Unusual Items: 182000.00
BIOV.SW income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 182000.00
BIOV.SW balance_sheet (annual, 2025-12-31) — Working Capital: 80975000.00
BIOV.SW balance_sheet (quarterly, 2025-12-31) — Working Capital: 80975000.00
BIOX cash_flow (annual, 2021-06-30) — Change In Account Payable: -5831743.00
BIOX cash_flow (annual, 2021-06-30) — Change In Income Tax Payable: 5814425.00
BIOX cash_flow (annual, 2021-06-30) — Change In Other Current Liabilities: -2821.00
BIOX cash_flow (annual, 2021-06-30) — Change In Tax Payable: 5814425.00
BIOX balance_sheet (annual, 2021-06-30) — Derivative Product Liabilities: 0.00
BIOX balance_sheet (annual, 2021-06-30) — Employee Benefits: 0.00
BIOX cash_flow (annual, 2021-06-30) — Gain Loss On Sale Of Business: 0.00
BIOX balance_sheet (annual, 2021-06-30) — Line Of Credit: 32838.00
BIOX balance_sheet (annual, 2021-06-30) — Loans Receivable: 230000.00
BIOX cash_flow (annual, 2021-06-30) — Net Short Term Debt Issuance: -3442491.00
BIOX cash_flow (annual, 2021-06-30) — Proceeds From Stock Option Exercised: -1030952.00
BIOX cash_flow (annual, 2021-06-30) — Purchase Of Business: -101883.00
BIOX balance_sheet (annual, 2021-06-30) — Restricted Cash: 425976.00
BIOX cash_flow (annual, 2021-06-30) — Short Term Debt Payments: -3442491.00
BIOX balance_sheet (annual, 2021-06-30) — Treasury Shares Number: 464455.00
BIOX income_statement (annual, 2022-06-30) — +Operating Expense: 80555406.00
BIOX income_statement (annual, 2022-06-30) — +Total Revenue: 328455588.00
BIOX balance_sheet (annual, 2022-06-30) — Accounts Payable: 124406072.00
BIOX balance_sheet (annual, 2022-06-30) — Accounts Receivable: 111752310.00
BIOX balance_sheet (annual, 2022-06-30) — Accumulated Depreciation: -21613129.00
BIOX balance_sheet (annual, 2022-06-30) — Additional Paid In Capital: 157903304.00
BIOX balance_sheet (annual, 2022-06-30) — Allowance For Doubtful Accounts Receivable: -9103715.00
BIOX income_statement (annual, 2022-06-30) — Amortization: 1634832.00
BIOX cash_flow (annual, 2022-06-30) — Amortization Cash Flow: 4161392.00
BIOX cash_flow (annual, 2022-06-30) — Amortization Of Intangibles: 4161392.00
BIOX income_statement (annual, 2022-06-30) — Amortization Of Intangibles Income Statement: 1634832.00
BIOX balance_sheet (annual, 2022-06-30) — Available For Sale Securities: 619841.00
BIOX income_statement (annual, 2022-06-30) — Basic Average Shares: 42302318.00
BIOX income_statement (annual, 2022-06-30) — Basic EPS: -0.17
BIOX cash_flow (annual, 2022-06-30) — Beginning Cash Position: 36046113.00
BIOX cash_flow (annual, 2022-06-30) — Capital Expenditure: -8997513.00
BIOX cash_flow (annual, 2022-06-30) — Capital Expenditure Reported: -5149684.00
BIOX balance_sheet (annual, 2022-06-30) — Capital Lease Obligations: 11751284.00
BIOX balance_sheet (annual, 2022-06-30) — Capital Stock: 4637.00
BIOX balance_sheet (annual, 2022-06-30) — Cash And Cash Equivalents: 33475266.00
BIOX balance_sheet (annual, 2022-06-30) — Cash Cash Equivalents And Short Term Investments: 38611276.00
BIOX cash_flow (annual, 2022-06-30) — Cash Dividends Paid: 0.00
BIOX balance_sheet (annual, 2022-06-30) — Cash Equivalents: 562380.00
BIOX balance_sheet (annual, 2022-06-30) — Cash Financial: 32912886.00
BIOX cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Financing Activities: 14823509.00
BIOX cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Investing Activities: 2903079.00
BIOX cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Operating Activities: -17515374.00
BIOX cash_flow (annual, 2022-06-30) — Change In Account Payable: 53477330.00
BIOX cash_flow (annual, 2022-06-30) — Change In Income Tax Payable: 6469983.00
BIOX cash_flow (annual, 2022-06-30) — Change In Inventory: -55311365.00
BIOX cash_flow (annual, 2022-06-30) — Change In Other Current Liabilities: -784.00
BIOX cash_flow (annual, 2022-06-30) — Change In Other Working Capital: -26747565.00
BIOX cash_flow (annual, 2022-06-30) — Change In Payable: 53477330.00
BIOX cash_flow (annual, 2022-06-30) — Change In Payables And Accrued Expense: 53477330.00
BIOX cash_flow (annual, 2022-06-30) — Change In Receivables: -32269886.00
BIOX cash_flow (annual, 2022-06-30) — Change In Tax Payable: 6469983.00
BIOX cash_flow (annual, 2022-06-30) — Change In Working Capital: -60851486.00
BIOX cash_flow (annual, 2022-06-30) — Changes In Account Receivables: -24971064.00
BIOX cash_flow (annual, 2022-06-30) — Changes In Cash: 211214.00
BIOX balance_sheet (annual, 2022-06-30) — Common Stock: 4637.00
BIOX balance_sheet (annual, 2022-06-30) — Common Stock Equity: 127614466.00
BIOX cash_flow (annual, 2022-06-30) — Common Stock Payments: 0.00
BIOX balance_sheet (annual, 2022-06-30) — Construction In Progress: 3142774.00
BIOX income_statement (annual, 2022-06-30) — Cost Of Revenue: 203680572.00
BIOX balance_sheet (annual, 2022-06-30) — Current Assets: 297705126.00
BIOX balance_sheet (annual, 2022-06-30) — Current Capital Lease Obligation: 1412904.00
BIOX balance_sheet (annual, 2022-06-30) — Current Debt: 71301468.00
BIOX balance_sheet (annual, 2022-06-30) — Current Debt And Capital Lease Obligation: 72714372.00
BIOX balance_sheet (annual, 2022-06-30) — Current Deferred Liabilities: 5895313.00
BIOX balance_sheet (annual, 2022-06-30) — Current Deferred Revenue: 5895313.00
BIOX balance_sheet (annual, 2022-06-30) — Current Liabilities: 222665752.00
BIOX cash_flow (annual, 2022-06-30) — Deferred Income Tax: 17972534.00
BIOX cash_flow (annual, 2022-06-30) — Deferred Tax: 17972534.00
BIOX cash_flow (annual, 2022-06-30) — Depreciation: 5026543.00
BIOX cash_flow (annual, 2022-06-30) — Depreciation Amortization Depletion: 9187935.00
BIOX income_statement (annual, 2022-06-30) — Depreciation Amortization Depletion Income Statement: 4694103.00
BIOX cash_flow (annual, 2022-06-30) — Depreciation And Amortization: 9187935.00
BIOX income_statement (annual, 2022-06-30) — Depreciation And Amortization In Income Statement: 4694103.00
BIOX income_statement (annual, 2022-06-30) — Depreciation Income Statement: 3059271.00
BIOX balance_sheet (annual, 2022-06-30) — Derivative Product Liabilities: 0.00
BIOX income_statement (annual, 2022-06-30) — Diluted Average Shares: 42302318.00
BIOX income_statement (annual, 2022-06-30) — Diluted EPS: -0.17
BIOX income_statement (annual, 2022-06-30) — Diluted NI Availto Com Stockholders: -7199618.00
BIOX balance_sheet (annual, 2022-06-30) — Duefrom Related Parties Current: 2988947.00
BIOX balance_sheet (annual, 2022-06-30) — Dueto Related Parties Current: 44579.00
BIOX balance_sheet (annual, 2022-06-30) — Dueto Related Parties Non Current: 717948.00
BIOX income_statement (annual, 2022-06-30) — EBIT: 29016620.00
BIOX income_statement (annual, 2022-06-30) — EBITDA: 38204555.00
BIOX income_statement (annual, 2022-06-30) — Earnings From Equity Interest: 1144418.00
BIOX cash_flow (annual, 2022-06-30) — Earnings Losses From Equity Investments: -1144418.00
BIOX cash_flow (annual, 2022-06-30) — Effect Of Exchange Rate Changes: 6842689.00
BIOX balance_sheet (annual, 2022-06-30) — Employee Benefits: 0.00
BIOX cash_flow (annual, 2022-06-30) — End Cash Position: 33475266.00
BIOX cash_flow (annual, 2022-06-30) — Financing Cash Flow: 14823509.00
BIOX balance_sheet (annual, 2022-06-30) — Finished Goods: 108430523.00
BIOX balance_sheet (annual, 2022-06-30) — Fixed Assets Revaluation Reserve: 1007272.00
BIOX balance_sheet (annual, 2022-06-30) — Foreign Currency Translation Adjustments: 969402.00
BIOX cash_flow (annual, 2022-06-30) — Free Cash Flow: -26512887.00
BIOX cash_flow (annual, 2022-06-30) — Gain Loss On Sale Of PPE: -1944308.00
BIOX income_statement (annual, 2022-06-30) — Gain On Sale Of Security: -9526873.00
BIOX balance_sheet (annual, 2022-06-30) — Gains Losses Not Affecting Retained Earnings: 1976674.00
BIOX income_statement (annual, 2022-06-30) — General And Administrative Expense: 42989595.00
BIOX balance_sheet (annual, 2022-06-30) — Goodwill: 36073685.00
BIOX balance_sheet (annual, 2022-06-30) — Goodwill And Other Intangible Assets: 112778554.00
BIOX balance_sheet (annual, 2022-06-30) — Gross Accounts Receivable: 120856025.00
BIOX balance_sheet (annual, 2022-06-30) — Gross PPE: 83665480.00
BIOX income_statement (annual, 2022-06-30) — Gross Profit: 124775016.00
BIOX balance_sheet (annual, 2022-06-30) — Income Tax Payable: 7538764.00
BIOX income_statement (annual, 2022-06-30) — Insurance And Claims: 1620959.00
BIOX income_statement (annual, 2022-06-30) — Interest Expense: 14952990.00
BIOX income_statement (annual, 2022-06-30) — Interest Expense Non Operating: 14952990.00
BIOX cash_flow (annual, 2022-06-30) — Interest Paid Cff: -13009834.00
BIOX cash_flow (annual, 2022-06-30) — Interest Received Cfo: 5628962.00
BIOX balance_sheet (annual, 2022-06-30) — Inventories Adjustments Allowances: -1104750.00
BIOX balance_sheet (annual, 2022-06-30) — Inventory: 126101435.00
BIOX balance_sheet (annual, 2022-06-30) — Invested Capital: 285652174.00
BIOX cash_flow (annual, 2022-06-30) — Investing Cash Flow: 2903079.00
BIOX balance_sheet (annual, 2022-06-30) — Investment Properties: 0.00
BIOX balance_sheet (annual, 2022-06-30) — Investmentin Financial Assets: 619841.00
BIOX balance_sheet (annual, 2022-06-30) — Investments And Advances: 39173933.00
BIOX cash_flow (annual, 2022-06-30) — Issuance Of Debt: 140431184.00
BIOX balance_sheet (annual, 2022-06-30) — Line Of Credit: 0.00
BIOX balance_sheet (annual, 2022-06-30) — Loans Receivable: 230000.00
BIOX balance_sheet (annual, 2022-06-30) — Long Term Capital Lease Obligation: 10338380.00
BIOX balance_sheet (annual, 2022-06-30) — Long Term Debt: 86736240.00
BIOX balance_sheet (annual, 2022-06-30) — Long Term Debt And Capital Lease Obligation: 97074620.00
BIOX cash_flow (annual, 2022-06-30) — Long Term Debt Issuance: 140431184.00
BIOX cash_flow (annual, 2022-06-30) — Long Term Debt Payments: -111660036.00
BIOX balance_sheet (annual, 2022-06-30) — Long Term Equity Investment: 38554092.00
BIOX balance_sheet (annual, 2022-06-30) — Long Term Provisions: 603022.00
BIOX balance_sheet (annual, 2022-06-30) — Machinery Furniture Equipment: 27719551.00
BIOX balance_sheet (annual, 2022-06-30) — Minority Interest: 30684382.00
BIOX income_statement (annual, 2022-06-30) — Minority Interests: -3290714.00
BIOX cash_flow (annual, 2022-06-30) — Net Business Purchase And Sale: 0.00
BIOX cash_flow (annual, 2022-06-30) — Net Common Stock Issuance: 0.00
BIOX balance_sheet (annual, 2022-06-30) — Net Debt: 124562442.00
BIOX income_statement (annual, 2022-06-30) — Net Income: -7199618.00
BIOX income_statement (annual, 2022-06-30) — Net Income Common Stockholders: -7199618.00
BIOX income_statement (annual, 2022-06-30) — Net Income Continuous Operations: -3908904.00
BIOX income_statement (annual, 2022-06-30) — Net Income From Continuing And Discontinued Operation: -7199618.00
BIOX income_statement (annual, 2022-06-30) — Net Income From Continuing Operation Net Minority Interest: -7199618.00
BIOX cash_flow (annual, 2022-06-30) — Net Income From Continuing Operations: -3908904.00
BIOX income_statement (annual, 2022-06-30) — Net Income Including Noncontrolling Interests: -3908904.00
BIOX cash_flow (annual, 2022-06-30) — Net Intangibles Purchase And Sale: -389039.00
BIOX income_statement (annual, 2022-06-30) — Net Interest Income: -17926197.00
BIOX cash_flow (annual, 2022-06-30) — Net Investment Purchase And Sale: 10275512.00
BIOX cash_flow (annual, 2022-06-30) — Net Issuance Payments Of Debt: 28738310.00
BIOX cash_flow (annual, 2022-06-30) — Net Long Term Debt Issuance: 28771148.00
BIOX income_statement (annual, 2022-06-30) — Net Non Operating Interest Income Expense: -17926197.00
BIOX cash_flow (annual, 2022-06-30) — Net Other Financing Charges: -904967.00
BIOX cash_flow (annual, 2022-06-30) — Net Other Investing Changes: -421691.00
BIOX balance_sheet (annual, 2022-06-30) — Net PPE: 62052351.00
BIOX cash_flow (annual, 2022-06-30) — Net PPE Purchase And Sale: -1412019.00
BIOX cash_flow (annual, 2022-06-30) — Net Short Term Debt Issuance: -32838.00
BIOX balance_sheet (annual, 2022-06-30) — Net Tangible Assets: 14835912.00
BIOX balance_sheet (annual, 2022-06-30) — Non Current Accounts Receivable: 2499023.00
BIOX balance_sheet (annual, 2022-06-30) — Non Current Deferred Assets: 4011374.00
BIOX balance_sheet (annual, 2022-06-30) — Non Current Deferred Liabilities: 29005943.00
BIOX balance_sheet (annual, 2022-06-30) — Non Current Deferred Revenue: 0.00
BIOX balance_sheet (annual, 2022-06-30) — Non Current Deferred Taxes Assets: 4011374.00
BIOX balance_sheet (annual, 2022-06-30) — Non Current Deferred Taxes Liabilities: 29005943.00
BIOX balance_sheet (annual, 2022-06-30) — Non Current Note Receivables: 0.00
BIOX income_statement (annual, 2022-06-30) — Normalized EBITDA: 47682696.00
BIOX income_statement (annual, 2022-06-30) — Normalized Income: -1038826.35
BIOX cash_flow (annual, 2022-06-30) — Operating Cash Flow: -17515374.00
BIOX cash_flow (annual, 2022-06-30) — Operating Gains Losses: -3088726.00
BIOX income_statement (annual, 2022-06-30) — Operating Income: 44219610.00
BIOX income_statement (annual, 2022-06-30) — Operating Revenue: 328455588.00
BIOX balance_sheet (annual, 2022-06-30) — Ordinary Shares Number: 45870346.00
BIOX cash_flow (annual, 2022-06-30) — Other Cash Adjustment Outside Changein Cash: -9624750.00